DBV Technologies SA
(NAS:DBVT)
$
0.88
-0.02 (-2.22%)
Market Cap: 88.51 Mil
Enterprise Value: 31.90 Mil
PE Ratio: 0
PB Ratio: 1.10
GF Score: 38/100 DBV Technologies SA (DBVT) Transcripts
- Full Year 2023 Dbv Technologies SA Earnings Call TranscriptMar 07, 2024$1.65 (-3.09%)Earnings
- Dbv Technologies SA to Discuss the EPOPEX Data Call TranscriptNov 09, 2023
- Q3 2023 Dbv Technologies SA Earnings Call TranscriptOct 31, 2023$2.02 (-3.81%)Earnings
- Half Year 2023 Dbv Technologies SA Earnings Call TranscriptJul 31, 2023$2.96 (-6.33%)Earnings
- Dbv Technologies SA at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Dbv Technologies SA at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Dbv Technologies SA FDA Regulatory Call TranscriptApr 19, 2023
- Full Year 2022 Dbv Technologies SA Earnings Call TranscriptMar 02, 2023$2.74 (-5.52%)Earnings
- Q3 2022 Dbv Technologies SA Earnings Call TranscriptNov 03, 2022$3.06 (+4.08%)Earnings
- Dbv Technologies SA to Discuss the VITESSE Study Call TranscriptSep 07, 2022
- Dbv Technologies SA to Discuss Positive Topline Results from Phase 3 EPITOPE Trial Call TranscriptJun 07, 2022
- Q1 2022 DBV Technologies SA Earnings Call TranscriptMay 02, 2022$2.77 (+7.36%)Earnings
- Full Year 2021 DBV Technologies SA Earnings Call TranscriptMar 03, 2022$3.5 (+34.62%)Earnings
- DBV Technologies SA Provides Update on Investigational Viaskinâ„¢ Peanut Corporate Call TranscriptDec 20, 2021
- Q3 2021 DBV Technologies SA Earnings Call TranscriptOct 26, 2021$10.1 (-1.56%)Earnings
- Half Year 2021 DBV Technologies SA Earnings Call TranscriptAug 02, 2021$10.74 (+3.27%)Earnings
- DBV Technologies SA at JMP Securities Life Sciences Virtual Conference TranscriptJun 16, 2021
- DBV Technologies SA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Full Year 2020 DBV Technologies SA Earnings Call TranscriptMar 11, 2021$10.48 (-2.78%)Earnings
- DBV Technologies SA at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- DBV Technologies SA To Provide An Update On Investigational Viaskin Peanut for Children Ages 4-11 Years Call TranscriptJan 14, 2021
- DBV Technologies SA at Evercore ISI HealthCONx Conference TranscriptDec 01, 2020
- DBV Technologies SA at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- DBV Technologies SA at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- DBV Technologies SA at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- DBV Technologies SA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- DBV Technologies SA - Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years - Conference Call TranscriptMar 16, 2020
- DBV Technologies SA at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- DBV Technologies SA at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- DBV Technologies SA at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- DBV Technologies SA To Provide Update on Regulatory Status of Viaskin Peanut for the Treatment of Peanut-Allergic Children Corporate Call TranscriptFeb 13, 2019
- 1